ArticleMedicine2016

Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT.

Jacob Farnebo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.